Atrial Natriuretic Peptide (ANP) Antibody (Biotin)

Este producto es parte de ANP - Atrial Natriuretic Peptide
Product Graph
351€ (200 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Atrial Natriuretic Peptide (ANP) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx272675
tested applications
WB, IHC, IF/ICC

Description

Atrial Natriuretic Peptide (ANP) Antibody (Biotin) is a Rabbit Polyclonal antibody conjugated to Biotin against Atrial Natriuretic Peptide (ANP).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Atrial Natriuretic Peptide (ANP)
Host
Rabbit
Reactivity
Mouse
Recommended Dilution
WB: 0.5-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Biotin
Isotype
IgG
Purification
Purified by antigen-specific affinity chromatography.
Size 1
200 µl
Size 2
1 ml
Form
Liquid
Tested Applications
WB, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-15 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
NPPA,ANF,ANP,ATFB6,Atrial natriuretic factor
Background
Antibody anti-ANP
Status
RUO

Descripción

Atrial Natriuretic Peptide (ANP) is a hormone secreted primarily by cardiac atrial myocytes in response to increased blood volume or pressure, playing a pivotal role in cardiovascular and fluid homeostasis. ANP exerts its effects by binding to natriuretic peptide receptor-A (NPR-A), leading to increased intracellular cyclic guanosine monophosphate (cGMP) levels, which mediate vasodilation and natriuresis. This hormone reduces systemic vascular resistance and promotes sodium and water excretion in the kidneys, thereby lowering blood pressure and blood volume. ANP is also a critical regulator of the renin-angiotensin-aldosterone system (RAAS), counteracting the effects of angiotensin II and aldosterone to prevent fluid overload. Clinically, elevated ANP levels are observed in conditions like heart failure and atrial fibrillation, serving as a biomarker for these diseases. Therapeutically, recombinant ANP and analogs are being explored for their potential in treating acute decompensated heart failure and hypertension. Research also highlights ANP’s role in protecting against cardiac hypertrophy, fibrosis, and remodeling, emphasizing its broader significance in cardiovascular health and disease management.

Related Products

EB0135

Bovine ANP (Atrial Natriuretic Peptide) ELISA Kit

Ver Producto
EGP0002

Guinea pig ANP (Atrial Natriuretic Peptide) ELISA Kit

Ver Producto
EH2639

Human ANP (Atrial Natriuretic Peptide) ELISA Kit

Ver Producto